Welcome


CMVHuman Cytomegalovirus (CMV) infection is common in the population; 90% of adults have antibodies to CMV. While in immunocompetent hosts CMV infection is usually asymptomatic, in immuno-compromised cohorts, including transplant recipients and HIV-infected individuals, CMV causes serious morbidity and mortality. Congenital CMV is the leading infectious cause of deafness and mental retardation in the United States. Approximately 40,000 new cases of congenital CMV infection are reported annually in the United States.

Our lab is working on the identification of new CMV inhibitors and on their mechanisms of action. As part of this effort, we are working on repurposing known drugs and on novel agents. Join us for an exciting journey towards novel strategies for CMV therapy.

Updates


Mar 2016
Updated lab members, list of publications

Apr 2014
Added clinical trials

Mar 2014
Updated members, research interests and publications

Nov 2013
Updated members and research area

Feb 2013
New Web site








   

Boger CMV Lab • boger@jhmi.edu